E. C. Lima

Increased Use of Antibiotics in the Intensive Care Unit During Coronavirus Disease (COVID-19) Pandemic in a Brazilian Hospital

I. Emmerick, D. R. Salgado, Luís Phillipe Nagem Lopes, 2021, Frontiers in Pharmacology.

Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow)

A. Carvalho-Assef, Fabricio Alves Barbosa Da Silva, A. R. Silva, 2022, Frontiers in Pharmacology.

Adverse reactions caused by antimicrobials in hospitalized pediatric patients: causality and avoidability analysis

M. Fonteles, E. C. Lima, Ronaldo Gomes Alexandre Júnior, 2022, Brazilian Journal of Pharmaceutical Sciences.

Drugs for rheumatoid arthritis provided by the Unified Health System in 2019 in Brazil: a cohort study.

M. Campos, V. Luiza, E. C. Lima, 2023, Ciencia & saude coletiva.

The Utility of the Liverpool Adverse Drug Reaction Assessment Tools in the Evaluation of Chemotherapy-Induced Nausea and Vomiting in Children

B. Pizer, L. Bracken, M. Peak, 2023, Revista Brasileira de Cancerologia.

Multisystem inflammatory syndrome drug treatment in countries with different income profiles: a scoping review

L. Lopes, M. Land, A. Fonseca, 2023, Frontiers in pharmacology.